Cenobamate for frequent seizures in the intensive care unit
Treatments studied
Part of Brain & nervous system clinical trials.
This trial tests a seizure medicine called cenobamate for people in the ICU who are having frequent seizures or a type of prolonged seizure called status epilepticus. It aims to see if this add-on treatment can help control seizures in this setting.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 70 years old.
- You are currently in the intensive care unit (ICU) and being monitored with an EEG (a test that records brain activity).
- You are having frequent seizures (more than 4 per hour) or a prolonged seizure lasting at least 5 minutes.
- You have not had a skin rash from any seizure medicine before.
- You are not taking certain medicines or devices that could affect how your body absorbs the study drug.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a medication called trospium chloride (often used for bladder problems) can improve memory and brain activity in people with epilepsy. Participants will receive the drug while undergoing brain monitoring for their epilepsy, and researchers will measure brain signals to see if it helps.
This trial tests a new device to help diagnose epilepsy in people whose previous EEG brain monitoring did not give clear answers. If you have drug-resistant epilepsy with at least one seizure a month on average, this study may help find better treatment options.
This study looks at how well cenobamate works when added to other seizure medications for adults with focal epilepsy. It uses real-world data from medical records to see how people respond to treatment.
This trial tests whether a new seizure medicine (cenobamate) helps people whose seizures are caused by an overactive immune system. You would stay on your current treatments and add cenobamate to see if it reduces seizures.
This study looks at how cenobamate (a medication for seizures) affects healthcare use, like hospital visits or emergency room trips, in people with epilepsy whose seizures were not well-controlled by 2 to 5 other medicines. It is a real-world study, meaning it uses medical records to understand the impact.
This trial studies the safety of cenobamate for Japanese people who have partial onset seizures and have already finished a previous study of the same drug. It helps doctors learn more about long-term safety.
Hear when a new Epilepsy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.